Physician profile
Devin Munk
NPI 1669112868
$3,052.70
in general payments reported to CMS, 2019-2025
16 companies · $891 in 2025
The $891 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $362 · 2023: $909 · 2024: $890 · 2025: $891.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,440 · Education: $251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,439.53 |
| Education | $251.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $600.84 | 2023-2025 | Ortholoc 3di, Prostep, Variax |
| Integra Lifesciences Corporation | $390.57 | 2022-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Axogen | $328.53 | 2023-2025 | Avance Nerve Graft |
| Paragon 28, INC. | $320.08 | 2024-2025 | Portfolio, Precision Mis Bunion, Phantom Fibula Nail |
| Medical Device Business Services, INC. | $251.00 | 2023 | |
| Acumed LLC | $166.95 | 2025 | Acumed |
| Medtronic, INC. | $131.29 | 2022-2025 | Intellis Adaptivestim |
| Progenacare Global, LLC | $126.62 | 2024 | |
| Abbvie INC. | $124.74 | 2024 | |
| Amgen INC. | $121.35 | 2024 | Krystexxa |
| Organogenesis INC. | $119.70 | 2023 | Puraply Antimicrobial |
| Horizon Therapeutics Plc | $114.80 | 2022 | |
| Heron Therapeutics, INC. | $105.46 | 2024 | Zynrelef |
| Zimmer Biomet Holdings, INC. | $69.97 | 2025 | |
| Pinnacle, INC | $51.69 | 2023-2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $29.11 | 2023 | Prevena, V.A.C. Veraflo, V.A.C.Ulta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devin Munk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.